Symbiotix develops molecular therapeutics based on the human microbiome... Read more
Symbiotix develops molecular therapeutics based on the human microbiome... Read more
News
Mar 22, 2018
Contract Pharma
Symbiotix Biotherapies: Symbiotix, Harvard Enter Collaboration
Jan 03, 2018
PharmiWeb
Symbiotix Biotherapies: Symbiotix Biotherapies Announces Process Development & Manufacturing Agreement with Paragon Bioservices
Nov 01, 2017
BioPortfolio
Symbiotix Biotherapies: Symbiotix Biotherapies Receives $5 Million in Institutional Financing to Advance its Development of Molecular Therapeutics that Modulate Regulatory T Cell Activity
Oct 11, 2017
VCCircle
Symbiotix Biotherapies: Lupin buys US-based Symbiomix Therapeutics for $150 mn